In the second largest RCT conducted on G-CSF treatment, Root et al. show that during severe sepsis secondary to pneumonia, G-CSF treatment does not improve patients’ outcome without any significant adverse event (72). Here, CSF3 is linked to susceptibility to pneumonia measurement.